*Candida auris* has been identified by the World Health Organization (WHO) as a critical priority pathogen due to its high mortality rates and resistance to multiple antifungal agents. The yeast can cause severe invasive infections, particularly in hospitalized and immunocompromised patients, with mortality rates ranging from 30% to 72%. The diagnosis of *C. auris* infections is challenging, especially using conventional techniques, which can hinder early detection and control measures. *C. auris* spreads easily in healthcare settings through contaminated environments or equipment and can persist for extended periods. Screening patients for *C. auris* colonization is crucial for identifying infected individuals and implementing appropriate prevention and control measures. The yeast is frequently resistant to drugs, with varying patterns of resistance observed among clades and geographical regions. This review provides an update on *C. auris*, covering epidemiology, clinical characteristics, genomic analysis, evolution, colonization, infection, identification, resistance profiles, therapeutic options, prevention, and control. The emergence of *C. auris* is attributed to factors such as climate change and human activity, leading to its rapid spread across continents. The review also discusses the challenges in diagnosing and treating *C. auris* infections, emphasizing the need for new antifungal agents and improved diagnostics.*Candida auris* has been identified by the World Health Organization (WHO) as a critical priority pathogen due to its high mortality rates and resistance to multiple antifungal agents. The yeast can cause severe invasive infections, particularly in hospitalized and immunocompromised patients, with mortality rates ranging from 30% to 72%. The diagnosis of *C. auris* infections is challenging, especially using conventional techniques, which can hinder early detection and control measures. *C. auris* spreads easily in healthcare settings through contaminated environments or equipment and can persist for extended periods. Screening patients for *C. auris* colonization is crucial for identifying infected individuals and implementing appropriate prevention and control measures. The yeast is frequently resistant to drugs, with varying patterns of resistance observed among clades and geographical regions. This review provides an update on *C. auris*, covering epidemiology, clinical characteristics, genomic analysis, evolution, colonization, infection, identification, resistance profiles, therapeutic options, prevention, and control. The emergence of *C. auris* is attributed to factors such as climate change and human activity, leading to its rapid spread across continents. The review also discusses the challenges in diagnosing and treating *C. auris* infections, emphasizing the need for new antifungal agents and improved diagnostics.